Compagnie Lombard Odier SCmA’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,543
Closed -$1.11M 482
2025
Q1
$1.11M Buy
+2,543
New +$1.02M 0.01% 159
2024
Q1
Sell
-1,200
Closed -$566K 542
2023
Q4
$566K Hold
1,200
0.01% 209
2023
Q3
$523K Buy
+1,200
New +$544K 0.01% 184
2023
Q2
Sell
-2,384
Closed -$1.1M 628
2023
Q1
$1.1M Buy
2,384
+947
+66% +$451K 0.03% 156
2022
Q4
$738K Buy
1,437
+237
+20% +$120K 0.02% 171
2022
Q3
$545K Hold
1,200
0.02% 209
2022
Q2
$579K Hold
1,200
0.01% 192
2022
Q1
$589K Hold
1,200
0.01% 194
2021
Q4
$556K Hold
1,200
0.01% 224
2021
Q3
$447K Sell
1,200
-238
-17% -$90.4K 0.01% 250
2021
Q2
$549K Sell
1,438
-700
-33% -$268K 0.01% 217
2021
Q1
$767K Hold
2,138
0.02% 234
2020
Q4
$686K Buy
2,138
+138
+7% +$42.4K 0.02% 192
2020
Q3
$537K Hold
2,000
0.02% 189
2020
Q2
$526K Sell
2,000
-100
-5% -$26.7K 0.02% 186
2020
Q1
$477K Buy
2,100
+1,200
+133% +$327K 0.02% 181
2019
Q4
$272K Sell
900
-140
-13% -$38.5K 0.01% 230
2019
Q3
$250K Buy
1,040
+800
+333% +$219K 0.01% 229
2019
Q2
$68K Sell
240
-5,160
-96% -$1.41M ﹤0.01% 342
2019
Q1
$1.55M Buy
5,400
+5,300
+5,300% +$1.53M 0.06% 128
2018
Q4
$26K Sell
100
-1,500
-94% -$412K ﹤0.01% 433
2018
Q3
$438K Hold
1,600
0.02% 219
2018
Q2
$381K Hold
1,600
0.01% 234
2018
Q1
$352K Buy
1,600
+1,334
+502% +$313K 0.01% 247
2017
Q4
$60K Buy
266
+166
+166% +$35.4K ﹤0.01% 527
2017
Q3
$19K Hold
100
﹤0.01% 610
2017
Q2
$19K Sell
100
-324
-76% -$58.2K ﹤0.01% 617
2017
Q1
$71K Buy
424
+31
+8% +$4.93K ﹤0.01% 494
2016
Q4
$56K Hold
393
﹤0.01% 595
2016
Q3
$50K Hold
393
﹤0.01% 679
2016
Q2
$51K Buy
393
+70
+22% +$9.58K ﹤0.01% 655
2016
Q1
$45K Hold
323
﹤0.01% 727
2015
Q4
$45K Buy
+323
New +$44.5K ﹤0.01% 703
2014
Q4
Sell
-5,514
Closed -$660K 791
2014
Q3
$660K Sell
5,514
-67
-1% -$7.68K 0.03% 263
2014
Q2
$600K Sell
5,581
-1,152
-17% -$119K 0.02% 283
2014
Q1
$670K Buy
6,733
+375
+6% +$33.9K 0.03% 271
2013
Q4
$587K Buy
+6,358
New +$565K 0.02% 290

Other funds holding ELV